Scitara Corp. Raises $ 15 Million in Series B Funding to Disrupt Laboratory Data Integration Market | Nation / World


MARLBOROUGH, Mass .– (BUSINESS WIRE) – January 11, 2022–

Scitara Corp., a proven innovator in the digital transformation of laboratories, today announces the completion of its Series B cycle with an additional investment of $ 15 million. Led by existing investor Northpond Ventures, with participation from Flybridge Capital and experienced financial advisors from the biopharmaceutical and life science tools industry, the funding will kick off Scitara’s ambitious growth plans for 2022 and beyond. in order to solve the challenge of integrating laboratory data.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220111005708/en/

(Photo: Business Wire)

Scitara’s growth has been fueled by the introduction of its industry-leading category Scientific Integration Platform ™ SIP ™, a cloud-native infrastructure that enables science labs to take full advantage of digital transformation. The Scitara SIP dramatically accelerates science by facilitating a modern, fully connected laboratory with data standardization, data mobility, flexibility and adaptability to a dynamic laboratory ecosystem.

Commenting on the Series B funding, Scitara Founder and CEO Ajit Nagral said, “This significant investment underscores the value of our offering to the global scientific community. Since the start of the pandemic, the global spotlight on science has never been sharper. As the life science and pharmaceutical industries are under monumental pressure to achieve breakthroughs at accelerating speeds, the importance of accurate real-time data retention has never been more critical. Science is turning to technology to help it digitize its processes and unlock the full potential of its data.

“Scientists need fast and transparent access to cross-functional data to advance their science. Scitara SIP integrates scientific data across the enterprise, and in tandem with artificial intelligence (AI) and analytical tools, scientists receive new information to accelerate decision-making and information to help accelerate product marketing. Therefore, the market demand for Scitara SIP has been unprecedented.

“Scitara SIP powered by our Digital Lab Exchange ™ DLX ™ platform brings a revolutionary level of laboratory automation and is designed to fully comply with the most stringent requirements of regulated markets. “

Andrea Jackson, Director of Northpond Ventures and Director of the Board of Directors of Scitara, added: “The way science flows in research and development is critical to accelerating the commercialization of life-saving therapies. Scitara’s platform enables seamless integration of data into laboratory workflows and operations. We strongly support Ajit and his team who are well positioned to drive a meaningful transformation in science. “

Chip Hazard, General Partner at Flybridge, commented on the agreement: “With an impressive roster of strategic partners that include leading instrument, IT and global service organizations, and a growing list of diverse customers. , including some of the world’s largest pharmaceutical companies, manufacturers and leading players in biotechnology, Scitara is leading the next generation of digital transformation in the lab. This fits perfectly with our portfolio of technology investments that move the industry forward. “

Scitara will use the Series B funding to accelerate platform innovation, deliver customer-focused technology offerings, grow its partner ecosystem, and build a community of scientists, developers and industry consultants to help respond to an ever-growing list of customer needs.

You can find more information on the advantages of Scitara SIP in the white paper Building the interconnected laboratory: Data mobility to support digital transformation.

About Scitara

Scitara is a global provider of cloud-based, industry-specific platforms and solutions for the life sciences industry. Based in Massachusetts, Scitara’s management brings decades of experience in solving digital challenges for the science lab: Meet the Modern Lab ™. For more information, please visit scitara.com.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20220111005708/en/

CONTACT: Lucy Shaw

[email protected]

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS

INDUSTRY KEYWORD: TECHNOLOGY SOFTWARE BIOTECHNOLOGY NETWORKS PHARMACEUTICAL HEALTH DATA MANAGEMENT OTHERS SCIENCE SCIENCE

SOURCE: Scitara Corp.

Copyright Business Wire 2022.

PUB: 11/01/2022 09:45 / DISC: 11/01/2022 09:47

http://www.businesswire.com/news/home/20220111005708/en

Copyright Business Wire 2022.

Previous New information on reform of actions that prevented Seattle researchers from testing community for COVID-19
Next China's Tianjin orders more tests on 14 million people